Patents by Inventor Naohisa Shobako

Naohisa Shobako has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BLOOD NEUTRAL FAT ESTIMATION DEVICE, BLOOD NEUTRAL FAT ESTIMATION METHOD, AND COMPUTER PROGRAM
    Publication number: 20240008814
    Abstract: Conventionally, a needle or the like needs to be inserted into skin of a subject to invasively collect blood in blood neutral fat measurement, which provides a psychological physical load on a subject. According to the present invention, it is possible to non-invasively estimate the blood neutral fat based on attribute information and/or non-invasive biological information of a predetermined user by generating a blood neutral fat estimation model by machine learning based on attribute information, non-invasive biological information, and blood examination data acquired from a plurality of subjects in advance.
    Type: Application
    Filed: March 28, 2022
    Publication date: January 11, 2024
    Applicant: NISSIN FOODS HOLDINGS CO., LTD.
    Inventors: Noritaka ANDO, Naohisa SHOBAKO
  • HbA1c RISK ESTIMATION DEVICE, HbA1c RISK ESTIMATION METHOD, AND COMPUTER PROGRAM
    Publication number: 20230402185
    Abstract: Conventionally, it has been necessary to collect blood of a subject and perform biochemical analysis to measure HbA1c. However, in this method, a needle or the like needs to be invasively inserted into the skin of the subject, which causes a psychological or physical burden on the subject. According to the present invention, it is possible to non-invasively estimate an HbA1c risk based on attribute information and/or non-invasive biological information of a predetermined user by generating an HbA1c risk estimation model by machine learning based on attribute information and non-invasive biological information acquired from a plurality of subjects in advance and examination data of a blood examination.
    Type: Application
    Filed: March 28, 2022
    Publication date: December 14, 2023
    Applicant: NISSIN FOODS HOLDINGS CO., LTD.
    Inventors: Noritaka ANDO, Naohisa SHOBAKO
  • BLOOD SUGAR LEVEL ESTIMATION DEVICE, BLOOD SUGAR LEVEL ESTIMATION METHOD, AND COMPUTER PROGRAM
    Publication number: 20230309866
    Abstract: In conventionally known methods, the blood sugar level is measured by collecting blood of a subject or predicted based on interstitial fluid. However, in any method, a needle or the like needs to be invasively inserted into the skin of the subject, which causes a psychological or physical burden on the subject. According to the present invention, it is possible to invasively estimate the blood sugar level based on attribute information and/or non-invasive biological information of a predetermined user by generating a blood sugar level estimation model by machine learning based on attribute information, non-invasive biological information, and blood examination data acquired from a plurality of subjects in advance.
    Type: Application
    Filed: March 28, 2022
    Publication date: October 5, 2023
    Applicant: NISSIN FOODS HOLDINGS CO., LTD.
    Inventors: Noritaka ANDO, Naohisa SHOBAKO
  • URIC ACID LEVEL ESTIMATION DEVICE, URIC ACID LEVEL ESTIMATION METHOD, AND COMPUTER PROGRAM
    Publication number: 20230317218
    Abstract: Conventionally, it has been necessary to collect blood of a subject and perform biochemical analysis to measure the uric acid level. However, in this method, a needle or the like needs to be invasively inserted into the skin of the subject, which provides a psychological or physical load on the subject. According to the present invention, it is possible to estimate the uric acid level based on attribute information and non-invasive biological information of a predetermined user by generating a uric acid level estimation model by machine learning based on attribute information, non-invasive biological information, and blood examination data acquired from a plurality of subjects in advance.
    Type: Application
    Filed: March 28, 2022
    Publication date: October 5, 2023
    Applicant: NISSIN FOODS HOLDINGS CO., LTD.
    Inventors: Noritaka ANDO, Naohisa SHOBAKO
  • Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof
    Patent number: 10676505
    Abstract: Provided is a novel peptide having ACE inhibitory activity. Specifically, provided is a tripeptide consisting of Leu-Arg-Ala.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: June 9, 2020
    Assignee: SUNSTAR INC.
    Inventors: Naohisa Shobako, Kousaku Ohinata, Yuutarou Ogawa, Etsuko Kobayashi, Atsushi Ishikado, Hirohisa Suidou, Takashi Kusakari
  • NOVEL TRIPEPTIDE
    Publication number: 20190233472
    Abstract: Provided is a novel peptide having ACE inhibitory activity. Specifically, provided is a tripeptide consisting of Leu-Arg-Ala.
    Type: Application
    Filed: June 16, 2017
    Publication date: August 1, 2019
    Applicant: SUNSTAR INC.
    Inventors: Naohisa SHOBAKO, Kousaku OHINATA, Yuutarou OGAWA, Etsuko KOBAYASHI, Atsushi ISHIKADO, Hirohisa SUIDOU, Takashi KUSAKARI